Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

被引：0

作者：

Carlo Visco

Alice Di Rocco

Andrea Evangelista

Francesca Maria Quaglia

Maria Chiara Tisi

Lucia Morello

Vittorio Ruggero Zilioli

Chiara Rusconi

Stefan Hohaus

Roberta Sciarra

Alessandro Re

Cristina Tecchio

Annalisa Chiappella

Ana Marin-Niebla

Rory McCulloch

Guido Gini

Tommasina Perrone

Luca Nassi

Elsa Pennese

Piero Maria Stefani

Maria Christina Cox

Valentina Bozzoli

Alberto Fabbri

Valentina Polli

Simone Ferrero

Maria Isabel Alvarez De Celis

Antonello Sica

Luca Petrucci

Luca Arcaini

Simon Rule

Mauro Krampera

Umberto Vitolo

Monica Balzarotti

机构：

[1] University of Verona,Department of Medicine, Section of Hematology

[2] Sapienza University,Department of Translational and Precision Medicine

[3] Azienda Ospedaliera Universitaria Città della Salute e della Scienza and CPO Piemonte,Unit of Clinical Epidemiology

[4] University of Verona,Department of Medicine, Section of Hematology

[5] San Bortolo Hospital,Cell Therapy and Hematology

[6] Humanitas Cancer Center,Humanitas Clinical and Research Center—IRCCS

[7] ASST Grande Ospedale Metropolitano Niguarda,Hematology

[8] IRCSS Istituto Nazionale Tumori,Hematology and Bone Marrow Transplantation

[9] Università Cattolica del Sacro Cuore,Hematology, Fondazione Policlinico Universitario A. Gemelli

[10] Fondazione IRCCS Policlinico San Matteo,Haematology

[11] Spedali Civili,Hematology

[12] “Città della Salute e della Scienza di Torino” University Hospital,Hematology

[13] Vall d’Hebron Institut of Oncology,Hematology

[14] University of Plymouth and Derriford Hospital,Haematology

[15] Department of Clinical and Molecular Sciences,Hematology

[16] Marche Polytechnic University,Hematology

[17] University of Bari,Hematology

[18] Azienda Ospedaliero-Universitaria Maggiore della Carità,Hematology

[19] UOSD “Centro Diagnosi e Terapia dei Linfomi”,Hematology

[20] PO Santo Spirito,Hematology

[21] General Hospital Ca’ Foncello,Hematology

[22] AOU Sant’Andrea,Hematology

[23] P.O. V. Fazzi,Hematology

[24] Azienda Ospedaliera Universitaria Senese & University of Siena,Hematology, Department of Molecular Biotechnologies and Health Sciences

[25] Ospedale degli Infermi,Hematology

[26] University of Torino/“Città della Salute e della Scienza di Torino” University Hospital,Hematology

[27] AUSLL/IRCCS Santa Maria Nuova Hospital,undefined

[28] Policlinico di Napoli,undefined

[29] Candiolo Cancer Institute,undefined

[30] FPO-IRCCS,undefined

来源：

Leukemia | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A Correction to this paper has been published: https://doi.org/10.1038/s41375-020-01119-8

引用

页码：932 / 932

共 50 条

[31] A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Sawalha, Yazeed
Goyal, Subir
Switchenko, Jeffrey M.
Romancik, Jason T.
Kamdar, Manali
Greenwell, I. Brian
Hess, Brian T.
Isaac, Krista M.
Portell, Craig A.
Garcia, Alex Mejia
Goldsmith, Scott
Grover, Natalie S.
Riedel, Peter A.
Karmali, Reem
Burkart, Madelyn
Buege, Michael
Akhtar, Othman
Torka, Pallawi
Kumar, Anita
Hill, Brian T.
Kahl, Brad S.
Cohen, Jonathon B.
BLOOD ADVANCES, 2023, 7 (13) : 2983 - 2993
[32] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
Trab, Trine
Chanchiri, Iman
Al-Mashhadi, Ahmed
Berggreen, Emma
Rasch, Stine
Johansen, Mette
Husby, Simon
Clausen, Michael Roost
Larsen, Thomas Stauffer
Desseau-Arp, Andriette C.
Christensen, Jacob Haaber
Pedersen, Robert Schou
Frederiksen, Mikael
Brown, Peter de Nully
El-Galaly, Tarec Christoffer
Gronbaek, Kirsten
BLOOD, 2024, 144 : 6325 - 6326
[33] Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
Yi, J. H.
Kim, W. S.
Kim, S. J.
Yoon, D. H.
Suh, C.
Chang, M. H.
Yang, D. H.
Jo, J-C.
Hyun, S. Y.
Eom, H-S.
Lee, J-O.
Kwon, J. H.
Han, S. H.
Lee, S-S.
Kwak, J-Y.
Kim, S. H.
ANNALS OF ONCOLOGY, 2019, 30
[34] Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
Jain, Preetesh
Kanagal-Shamanna, Rashmi
Zhang, Shaojun
OK, Chi Young
Navsaria, Lucy
Nastoupil, Loretta
Lee, Hun Ju
Tang, Guilin
Yin, C. Cameron
Badillo, Maria
Nair, Ranjit
Li, Shaoying
Patel, Keyur M.
Flowers, Christopher
Vega, Francisco
Wang, Linghua
Wang, Michael L.
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E137 - E140
[35] Clinical Efficacy and Management of Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Coiffier, Bertrand
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 351 - 359
[36] SALVAGE TREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MANTLE CELL LYMPHOMA
Zaja, F.
De Luca, S.
Vitolo, U.
Orsucci, L.
Levis, A.
Salvi, F.
Gargantini, L.
Ravelli, E.
Tucci, A.
Bottelli, C.
Balzarotti, M.
Santoro, A.
Brusamolino, E.
Bonfichi, M.
Di Rocco, A.
Stelitano, C.
Baldini, L.
Pileri, S.
Volpetti, S.
Saccona, F.
Ciccone, G.
Ferranti, A.
Fanin, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 115 - 115
[37] Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study
Morschhauser, Franck
Bouabdallah, Kamal
Stilgenbauer, Stephan
Thieblemont, Catherine
de Guibert, Sophie
Zettl, Florian
Gelbert, Lawrence M.
Turner, P. Kellie
Kambhampati, Siva Rama Prasad
Li, Li
Li, Lily Q.
Buchanan, Sean
Barriga, Susana
Bear, Melissa M.
Wilhelm, Martin
Hess, Georg
HAEMATOLOGICA, 2021, 106 (03) : 859 - 862
[38] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
Maruyama, Dai
Nagai, Hirokazu
Fukuhara, Noriko
Kitano, Toshiyuki
Ishikawa, Takayuki
Shibayama, Hirohiko
Choi, Ilseung
Hatake, Kiyohiko
Uchida, Toshiki
Nishikori, Momoko
Kinoshita, Tomohiro
Matsuno, Yoshihiro
Nishikawa, Tomoaki
Takahara, Satoko
Tobinai, Kensei
CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
[39] Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe
Aydilek, Enver
Wulf, Gerald
Schwarz, Friedrich
Bacher, Ulrike
Rummel, Mathias
Stiefel, Olga
Kerkhoff, Andrea
Maulhardt, Markus
Melchardt, Thomas
Pabst, Thomas
Lenz, Georg
Shumilov, Evgenii
CANCER MEDICINE, 2024, 13 (10):
[40] Outcomes of Acalabrutinib Failures in Relapsed Mantle Cell Lymphoma
Jain, Preetesh
Zhang, Shaojun
Kanagal-Shamanna, Rashmi
Navsaria, Lucy
Ok, Chi Young
Tang, Guilin
Yin, C. Cameron
Badillo, Maria
Chen, Wendy
Oriabure, Onyeka
Lee, Hun Ju
Westin, Jason
Nastoupil, Loretta J.
Moghrabi, Omar
Che, Yuxuan
Samaniego, Felipe
Ahmed, Sairah
Nair, Ranjit
Li, Shaoying
Vega, Francisco
Flowers, Christopher
Wang, Linghua
Wang, Michael
BLOOD, 2020, 136

← 1 2 3 4 5 →